Precision Therapy for Recurring Lung Cancer Patients

News   Mar 21, 2017 | Original story from University of Texas M. D. Anderson Cancer Center.

 
Precision Therapy for Recurring Lung Cancer Patients

Credit: University of Texas M. D. Anderson Cancer Center.

 
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

Cambridge Epigenetix, NuGEN Technologies Sign Agreement to Combine Leading Technologies in Epigenetics Research

News

Cambridge Epigenetix and NuGEN Technologies come together to integrate the oxidative bisulfite sequencing (oxBS-Seq) with NGS library preparation kits.

READ MORE

Why Combining Two Checkpoint Inhibitors is More Effective Than Using Them in Isolation

News

A team at the MD Anderson Cancer center team has found that checkpoint inhibitors fire up different types of T cells to attack tumors

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE